Clinical and molecular characteristics of extramedullary acute myeloid leukemias
Leukemia
.
2024 Sep;38(9):2032-2036.
doi: 10.1038/s41375-024-02337-0.
Epub 2024 Jul 18.
Authors
Tariq Kewan
1
2
,
Waled S Bahaj
1
,
Carmelo Gurnari
1
3
,
Olisaemeka D Ogbue
1
,
Sudipto Mukherjee
1
,
Anjali Advani
1
,
James R Cook
4
,
Heesun J Rogers
4
,
Hetty E Carraway
1
,
Suresh K Balasubramanian
5
,
Valeria Visconte
1
,
Jaroslaw P Maciejewski
6
Affiliations
1
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
2
Department of Hematology and Oncology, Yale University, New Haven, CT, USA.
3
Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
4
Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA.
5
Department of Hematology and Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
6
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
[email protected]
.
PMID:
39020062
PMCID:
PMC11347362
DOI:
10.1038/s41375-024-02337-0
No abstract available
Publication types
Letter
MeSH terms
Adolescent
Adult
Aged
Aged, 80 and over
Female
Humans
Leukemia, Myeloid, Acute* / genetics
Leukemia, Myeloid, Acute* / pathology
Male
Middle Aged
Mutation
Prognosis
Young Adult
Grants and funding
R01 HL118281/HL/NHLBI NIH HHS/United States
R01 HL123904/HL/NHLBI NIH HHS/United States
R01 HL132071/HL/NHLBI NIH HHS/United States
R35 HL135795/HL/NHLBI NIH HHS/United States